Back

Impact of heart failure chronicity on long-term outcomes after cardiac resynchronization therapy

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - treatment 4 Cardiac Resynchronisation Therapy (CRT) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Eugeniu Grama

Germans Trias i Pujol Hospital, Barcelona (Spain)

6 More presentations in this session

Presentation thumbnail
Elevating patient care: effective screening strategies to detect pacemaker induced cardiomyopathy
Doctor C. Seyani (Southampton, GB)
Abstract Slides Video
Presentation thumbnail
Timing CRT implantation in heart failure: an analysis on LVEF recovery and device implantation
Doctor M. Raposo (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Optimizing CRT response in atrial fibrillation: unraveling the role of mitral valve regurgitation reduction for enhanced patient outcomes
Mr A. Rocha De Almeida (Evora, PT)
Abstract Slides Video
Presentation thumbnail
The relationship between handgrip strength and peak oxygen uptake in cardiovascular resynchronisation therapy patients
Mr M. Wickens (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Impact of right ventricular dimension and function on outcomes in patients undergoing cardiac resynchronization therapy
Doctor F. Rodrigues Santos (Viseu, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - treatment 4

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Long term clinical outcome and echocardiographic response of patients submitted to upgrade to cardiac resynchronization therapy
thumbnail
Congress Presentation
Cardiac resynchronization therapy - beyond ejection fraction
thumbnail
Congress Presentation
Differential outcomes of cardiac resynchronization therapy based on heart failure etiology

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources